Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications metabolically healthy obesity risk incident ischemic heart disease stroke ���
… Economics: Database Studies Pharmacoepidemiology and Risk Management Staff Members Alicia Gilsenan Bradley Layton …
… and cholera epidemics by minimizing the costs of cases and disease-management strategies under different policy … to explore physiological control mechanisms governing heart-rate variability from patient heart rate, blood pressure, and respiration data. Dr. Fox’s …
HTA and Reimbursement Considerations for Orphan Drugs in European Markets HTA and Reimbursement Considerations for Rare Diseases in European Markets: What Are the Implications for Manufacturers? Heyes A, McBride D, Pearson I, Copley-Merriman C …
… collection through to transfusion. They found that the risk of adverse events was small for both methods, but the … it is acknowledged that PRT is associated with reduced risk of contamination because of emerging viral pathogens and …
… and safety.” Related Services Pharmacoepidemiology and Risk Management Staff Members Bradley Layton …
… HS in 2005, he has focused on safety studies evaluating disease natural history and incidence of and risk factors for rare adverse outcomes potentially associated … gynecology, urology, neurology, and respiratory disease. Mr. Midkiff has considerable experience supervising …
… and usability testing of COA measures focused on disease symptoms, health-related quality of life, treatment … women's health, diabetes, insomnia, Parkinson's disease, heart failure, stuttering, Cushing's disease, … national meetings. She has also co-authored peer-reviewed publications in multiple disease areas summarizing the most …
… areas, including dermatology, gastroenterology, diabetes, obesity, chronic pain, ophthalmology, rhinosinusitis, Alzheimer's disease, Huntington's disease, alcohol and opioid use disorders, and rare genetic …
… and consumers’ knowledge, attitudes, and perceptions of a disease for which there is currently not a vaccine available. … milestones across the studies, while meeting deadlines for publications. OUR APPROACH We assembled a core team of …
… studies Economic burden of illness studies Epidemiology of disease Exploratory analyses of clinical trial data Global …